Pembrolizumab versus the standard of care for relapsed and refractory classical Hodgkin's lymphoma progressing after brentuximab vedotin: an indirect treatment comparison. [electronic resource]

By: Contributor(s): Producer: 20190228Description: 503-511 p. digitalISSN:
  • 1747-4094
Subject(s): Online resources: In: Expert review of hematology vol. 11
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Systematic Review

There are no comments on this title.

to post a comment.
Previous
Back to results
Next
Close